Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Prothrombin prevents fatal T cell–dependent anemia during chronic virus infection of mice
Rachel Cantrell, H. Alex Feldman, Leah Rosenfeldt, Ayad Ali, Benjamin Gourley, Cassandra Sprague, Daniel Leino, Jeff Crosby, Alexey Revenko, Brett Monia, Stephen N. Waggoner, Joseph S. Palumbo
Rachel Cantrell, H. Alex Feldman, Leah Rosenfeldt, Ayad Ali, Benjamin Gourley, Cassandra Sprague, Daniel Leino, Jeff Crosby, Alexey Revenko, Brett Monia, Stephen N. Waggoner, Joseph S. Palumbo
View: Text | PDF
Research Article Hematology Immunology

Prothrombin prevents fatal T cell–dependent anemia during chronic virus infection of mice

  • Text
  • PDF
Abstract

Thrombin promotes the proliferation and function of CD8+ T cells. To test if thrombin prevents exhaustion and sustains antiviral T cell activity during chronic viral infection, we depleted the thrombin-precursor prothrombin to 10% of normal levels in mice prior to infection with the clone 13 strain of lymphocytic choriomeningitis virus. Unexpectedly, prothrombin insufficiency resulted in 100% mortality after infection that was prevented by depletion of CD8+ T cells, suggesting that reduced availability of prothrombin enhances virus-induced immunopathology. Yet, the number, function, and apparent exhaustion of virus-specific T cells were measurably unaffected by prothrombin depletion. Histological analysis of the lung, heart, liver, kidney, spleen, intestine, and brain did not reveal any evidence of hemorrhage or increased tissue damage in mice with low levels of prothrombin that could explain mortality. Viral loads were also similar in infected mice regardless of prothrombin levels. Instead, infection of prothrombin-depleted mice resulted in a severe, T cell–dependent anemia associated with increased hemolysis. Thus, thrombin plays an unexpected protective role in preventing hemolytic anemia during virus infection, with potential implications for patients who are using direct thrombin inhibitors as an anticoagulant therapy.

Authors

Rachel Cantrell, H. Alex Feldman, Leah Rosenfeldt, Ayad Ali, Benjamin Gourley, Cassandra Sprague, Daniel Leino, Jeff Crosby, Alexey Revenko, Brett Monia, Stephen N. Waggoner, Joseph S. Palumbo

×

Figure 4

Magnitude of antiviral T cell responses is independent of prothrombin.

Options: View larger image (or click on image) Download as PowerPoint
Magnitude of antiviral T cell responses is independent of prothrombin.
G...
Groups of C57BL/6 mice were treated with ASO to deplete prothrombin (FIIlo) or control ASO (Control) prior to i.v. infection with 2 × 106 PFU of the clone 13 strain of LCMV. (A–E) On day 8 of infection, antiviral T cell responses were analyzed in splenocytes (n = 7–8 mice/group) following in vitro restimulation with LCMV-derived peptides. (A) Representative gating of CD4+ and CD8+ T cells among live, singlet lymphocytes as well as subsequent gating of CD44+CD43+, IFN-γ+, IFN-γ+TNF+ T cells is shown. The proportions and absolute numbers of activated CD44+CD43+ (B) CD8+ and (C) CD4+ T cells as well as (D) IFN-γ+CD8+ T cells and (E) IFN-γ+CD4+ T cells stimulated with the noted viral peptides are presented. (F) For measurement of in vivo CTL function, splenocytes from uninfected mice were labeled with 3 different concentrations of CFSE, pulsed with viral-specific peptides (no peptide, GP33–41, or NP396–404) and i.v. transferred in a 1:1:1 ratio into prothrombin-depleted (FIIlo) or control mice 5 days after infection (n = 6 mice/group). Representative histogram of CFSE-labeled target cell recovery from a recipient mouse and mean (± SEM) calculated lysis of GP33–41– or NP396–404–labeled target cells relative to unlabeled controls are plotted. Statistical significance was determined by unpaired Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts